Clinical Trial Update: S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 study sponsored by NIDDK evaluated S-Adenosyl Methionine (SAMe) for chronic hepatitis C; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• S-Adenosyl Methionine (SAMe) (S-adenosyl-L-methionine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2013-07-05